Company Overview and News

BOURBON : Convocation de l'Assemblée Générale des porteurs de TSSDI de BOURBON Corporation

2018-04-05 globenewswire
Les porteurs d'obligations perpétuelles subordonnées de dernier rang (TSSDI) à taux fixe à variable (Undated Deeply Subordinated Fixed to Floating Rate Bonds) émises par la société au titre d'une émission initiale d'un montant total en principal de 100 millions d'euros le 24 octobre 2014 et d'une seconde émission d'obligations assimilées et formant une souche unique avec les obligations initiales, d'un montant total en principal de 20 millions d'euros le 24 avril 2015, sont convoqués en assemblée générale le 20 avril 2018 à 14h30 à l'EMD, Montée de l'Université, rue Joseph Biaggi à Marseille (France).
Upvote Downvote

BOURBON: Convening to the general meeting of the holders of BOURBON Corporation's Bonds

2018-04-05 globenewswire
The holders of Undated Deeply Subordinated Fixed to Floating Rate Bonds (the "Bonds" and the "Bondholders") issued by the company under an initial issuance for a total principal amount of €100 million on October 24, 2014 and a second issuance of assimilated bonds and forming a single series with the initial bonds, for a total principal amount of €20 million on April 24, 2015, are convened to the general meeting of Bondholders on April 20, 2018, at 2:30 p.
Upvote Downvote

Geopolitical Risk Remains In The Background

2018-03-30 seekingalpha
A Eurogroup meeting on March 12 has been the key moment for the Brexit negotiations. At this meeting, the Europeans set the guidelines for their transition period discussions with the UK, aiming for a fully crafted withdrawal agreement by October or November.
Upvote Downvote

'Monstrosity': City of Sydney joins residents in rubbishing Kings Cross redevelopment

A long night at the Bourbon and Beefsteak Bar in 1999 left former Australian cricket captain Ricky Ponting with a black eye.
Upvote Downvote

Charlie Pickering's police gaffe casts pall over ABC's fireworks countdown

Charlie Pickering on ABC TV Countdown to the New Year's Eve fireworks said it's OK to kill – oops kiss – police. How appalling. These people do such a great job.
Upvote Downvote

Smaller Bourbon but plenty of apartments promised in Kings Cross overhaul

Some of the most iconic sights of Kings Cross, including the historic old former Bourbon & Beefsteak and the building that housed Les Girls, would be demolished in a massive redevelopment program poised to change the face of the area.
Upvote Downvote

‘Big Brother Canada’ Season 6 auditions: Casting tour going coast to coast

Sponsored content is written by Global News' editorial staff without any editorial influence by the sponsor. If you'd like to learn more...
Upvote Downvote

Nordic American Offshore - Leveraged Bet On Future Market For Offshore Supply Vessels

2017-04-20 seekingalpha
North American Offshore (NYSE:NAO) shares recently got pounded because of plunging ship prices left it in a liquidity crisis. They did not necessarily have to issue shares as the company remained solvent but the Executive Chairman of NAO, Mr. Herbjørn Hansson is deeply conservative and led the effort to issue 41 million new shares to make NAO the only pure-play provider who is not in violation of its original debt covenants from debt issued during the boom years.
Upvote Downvote

Bikie boss Felix Lyle facing deportation to New Zealand

One of the country's most notorious crime figures, bikie boss Felix Lyle, is fighting an order that he be deported to New Zealand.
Upvote Downvote

4 Disturbing Visuals Show How Disconnected Stocks Are From FX Reality

2017-01-26 seekingalpha
"Today is the day. From today on, I'm going to take a break every night from 6 until at least 8."
Upvote Downvote

UK Economy Continues to Grow Despite Brexit: ETFs in Focus

2016-11-30 zacks
Dispelling fears of an immediate recession, the UK economy grew 0.5% in the third quarter. This quarter marks the 15th consecutive quarter of growth for the economy. Going by the third quarter numbers, UK still appears to be one of the strongest growing economies in Europe (read: UK ETFs in Focus As the Economy Defies Brexit Fears). The growth was supported by an increase in export and stronger consumer spending.
Upvote Downvote

Currency ETF Winners & Losers Post Trump Win

2016-11-16 zacks
The U.S. dollar received a fresh lifeline with Trump’s win in the presidential election. The currency has been downbeat this year on not-so-robust U.S. economic growth and low interest rates prevailing in the country (read: The Trump Effect: 8 Must-See ETF Charts).
Upvote Downvote

Inside secret 19th-century tunnel under Naples that used to be escape route for the king | Daily Mail Online

Layered with history, as mesmerising as Naples is above ground the ancient city is also home to a mysterious warren of tunnels carved into 16th century aqueducts, 100 feet below ground.
Upvote Downvote

‘Big Brother Canada’ Season 5 auditions: Casting tour stops across Canada

Sponsored content is written by Global News' editorial staff without any editorial influence by the sponsor. If you'd like to learn more...
Upvote Downvote

Eight Beers to Drink This Summer That Aren’t IPAs - Bloomberg

2016-07-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...